← Insider buys
IVVD

Invivyd, Inc. · Healthcare

Chief Scientific Officer Robert D. Allen III sold $59K of Invivyd, Inc.

Sold$58,600
$1.56Price
37,581Shares
−25%Stake

What IVVD did after the filing

Filed Feb 18, copier in the same day
The stock from Wed, Feb 18 close, $1.65
−19.4%
S&P 500, same days
−4.5%

Measured over 30 trading days, to the Apr 1 close.

Traded Tue, Feb 17. Filed Wed, Feb 18, 3:56 PM ET, during the session. Returns use the Feb 18 close and the Apr 1 close. Not investment advice.